Does ALEMTUZUMAB Cause Cholecystitis? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Cholecystitis have been filed in association with ALEMTUZUMAB (Campath). This represents 0.3% of all adverse event reports for ALEMTUZUMAB.
46
Reports of Cholecystitis with ALEMTUZUMAB
0.3%
of all ALEMTUZUMAB reports
2
Deaths
26
Hospitalizations
How Dangerous Is Cholecystitis From ALEMTUZUMAB?
Of the 46 reports, 2 (4.3%) resulted in death, 26 (56.5%) required hospitalization, and 11 (23.9%) were considered life-threatening.
Is Cholecystitis Listed in the Official Label?
Yes, Cholecystitis is listed as a known adverse reaction in the official FDA drug label for ALEMTUZUMAB.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Cholecystitis?
LENVATINIB (309)
SEMAGLUTIDE (293)
PEMBROLIZUMAB (245)
ADALIMUMAB (234)
METHOTREXATE (205)
NIVOLUMAB (183)
RITUXIMAB (159)
LENALIDOMIDE (144)
BEVACIZUMAB (131)
CYCLOPHOSPHAMIDE (131)
Which ALEMTUZUMAB Alternatives Have Lower Cholecystitis Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET